{
    "pmcid": "8765073",
    "qa_pairs": {
        "How many antibody design models were initially considered before selecting candidates for further validation?": [
            "Approximately 1000",
            "Approximately 500",
            "Approximately 2000",
            "Approximately 1500"
        ],
        "What computational tool was primarily used to design and optimize antibodies against the SARS-CoV-2 RBD?": [
            "Rosetta",
            "AutoDock",
            "GROMACS",
            "PyMOL"
        ],
        "What was the final antibody variant that exhibited ultra-potent binding affinity for various SARS-CoV-2 variants?": [
            "D27LEY",
            "D27XYZ",
            "D27ABC",
            "D27QRS"
        ],
        "What was the name of the lead antibody identified through biolayer interferometry experiments?": [
            "D27",
            "B12",
            "C19",
            "E45"
        ],
        "Which mutation in SARS-CoV-2 variants was specifically addressed during computational affinity maturation?": [
            "N501Y",
            "D614G",
            "E484K",
            "P681R"
        ]
    }
}